Evidence map›Paper›PMID 33551717›Full record

ArticleFrontiers in neuroscience2020

Genomic and Epigenetic Advances in Focal Cortical Dysplasia Types I and II: A Scoping Review.

Joana Jesus-Ribeiro, Luís Miguel Pires, João Daniel Melo, Ilda Patrícia Ribeiro, Olinda Rebelo, Francisco Sales, António Freire, Joana Barbosa Melo

Open access · goldAbstract readScoping Review
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The regulatory function of lncRNA and constructed network in epilepsy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Screening and identification of novel candidate biomarkers of focal cortical dysplasia type II via bioinformatics analysis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2022
    Article
  14. Article
  15. MRI of focal cortical dysplasia.Neuroradiology · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. The Epigenome in Neurodevelopmental Disorders.Frontiers in neuroscience · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Joana Jesus-RibeiroEpilepsy and Sleep Monitoring Unit, Neurology Department, Coimbra University Hospital Center, Coimbra, Portugal.
Luís Miguel PiresiCBR/CIMAGO, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
João Daniel MeloCUF Coimbra Hospital, Coimbra, Portugal.
Ilda Patrícia RibeiroiCBR/CIMAGO, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Olinda RebeloNeuropathology Laboratory, Neurology Department, Coimbra University Hospital Center, Coimbra, Portugal.
Francisco SalesEpilepsy and Sleep Monitoring Unit, Neurology Department, Coimbra University Hospital Center, Coimbra, Portugal.
António FreireFaculty of Medicine, University of Coimbra, Coimbra, Portugal.
Joana Barbosa MeloiCBR/CIMAGO, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
University of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA methylationdrug-resistant epilepsyepigeneticsfocal cortical dysplasiagenomicsmicroRNAsmTOR pathwayscoping review

Identifiers

PMID33551717
PMCPMC7862327
OpenAlexW3122009574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.